Home > Insider Trading > Filing (0001123292-19-000618)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
881524	Vivus Inc	VVUS	Pharmaceutical Preparations (2834)	943136179

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1738557	P. John Amos	C/O Vivus, Inc. 900 E. Hamilton Ave., Suite 550 Campbell CA 95008	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-03-01	11,000	$4.85	181,850	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This is the weighted average purchase price. Shares were purchased in multiple transactions at prices from $4.76 to $4.86. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. The amount reflected has been rounded to 4 decimal points.
On September 10, 2018, VIVUS, Inc. effected a 1-for-10 reverse stock split (the "Reverse Split"). The number of shares in the original Form 4 was not adjusted to reflect the Reverse Split. 1,708,500 shares of common stock on a pre-Reverse Split basis were adjusted to 170,850 shares following the Reverse Split (with fractional shares rounded up to the next whole number). The number of shares beneficially owned following the reported transaction has been adjusted to reflect the Reverse Spit.